Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported the transaction details related to the repurchases of its own common shares made in the period from November 3, 2017 up to and including November 9, 2017. These repurchases were made under the repurchase program to cover long-term incentive and employee share purchase plans, which was announced on October 30, 2017. Further details can be found in the table below and via this link.*
| | |
| | |
| | |
| | |
| | |
| | |
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Philips Global Press Office Tel: +31 6 1521 3446
You are about to visit a Philips global content page
Continue Philips Investor Relations Tel: +31 20 59 77055
You are about to visit a Philips global content page
ContinueGet our press releases by e-mail
You are about to visit a Philips global content page
Continue